diazooxonorleucine and Benign Cerebellar Neoplasms

diazooxonorleucine has been researched along with Benign Cerebellar Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alt, J; Eberhart, CG; Maxwell, MJ; Pham, K; Raabe, EH; Rais, R; Slusher, BS; Sweeney, H	1

Other Studies

1 other study(ies) available for diazooxonorleucine and Benign Cerebellar Neoplasms

Article	Year
Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis. Journal of neuropathology and experimental neurology, 2021, 03-22, Volume: 80, Issue:4 Topics: Animals; Apoptosis; Caproates; Cell Line, Tumor; Cerebellar Neoplasms; Diazooxonorleucine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Glutamine; Humans; Medulloblastoma; Mice; Mice, Nude	2021

Article

Year

Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.

Journal of neuropathology and experimental neurology, 2021, 03-22, Volume: 80, Issue:4

Topics: Animals; Apoptosis; Caproates; Cell Line, Tumor; Cerebellar Neoplasms; Diazooxonorleucine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Glutamine; Humans; Medulloblastoma; Mice; Mice, Nude

2021